Julien Alberici

Octalfa SAS is a family-owned, independent private equity holding and investment company controlled by Gilles Alberici. Octalfa was established in 2006 and is based near Lyon in Eastern France. The firm manages a portfolio of participations in Life Sciences companies. They are also the key investor of Octalfa 360 Health and Green Technologies, a sector mutual fund invested in listed equity, co-managed by 360 Asset Managers SA and Xénia SARL (aka Xénia Gestion Privée). The fund focuses on sectors such as biotechnology and clean technology. Octalfa is committed to public health issues, and established the Dominique Alberici-Octalfa Corporate Foundation to support initiatives aimed at improving medical and paramedical care for cancer patients and the disabled.

Mathym SAS engages in the development, manufacture, and commercialization of colloidal solutions for biomedical applications. It specializes in nano-dispersions. The company was founded by Julien Alberici and Frederic Chaput in September 1, 2013 and is headquartered in Champagne-au-Mont-d'Or, France.

ORPHELIA Pharma SA specializes on biopharmaceutical products improving the health and well being of severely disabled children. The company was founded by Hugues Bienaymé in 2007 and is headquartered in Paris, France.